External validation of a nomogram for the prediction of 10-year life expectancy in candidates for radical prostatectomy
- 56 Downloads
Accurate life expectancy prediction is essential in decision-making concerning treatment of clinically localized prostate cancer (PCa). Nomogram predictions are more precise and reproducible than clinician’s estimations. The most accurate nomogram addressing 10-year life expectancy in PCa patients has not been externally validated to date. Therefore, we aimed to evaluate the performance of this nomogram in a contemporary external cohort.
Patients and methods
For this, we enrolled all consecutive patients, who underwent radical prostatectomy at a single institution between 2005 and 2007. Age at surgery and Charlson Comorbidity Index (CCI) were assessed. PCa-related deaths and patients under 55 years were excluded as indicated by the nomogram. The prediction of 10-year life expectancy was calculated according to the nomogram and compared to actual survival data. Calibration and discrimination were assessed using calibration plots.
Overall, 1597 patients were evaluated, with a median age of 64 years (range 55–78 years) at surgery and a median follow-up of 134.4 months (range 0.1–161.7 months). Median CCI was 0 (range 0–10). At 10 years, 134 patients (8.4%) had died of other causes than PCa. The nomogram showed moderate discrimination capacities on receiver-operator characteristic analysis (c-index: 0.64). On calibration curves, the nomogram underestimated the actual life expectancy.
The performance accuracy of this prediction model was moderate and underestimated 10-year life expectancy of contemporary PCa patients. In conclusion, prediction of life expectancy remains challenging with a continued need for more precise tools.
KeywordsProstate cancer Life expectancy External validation Prediction model Nomogram
There was no external financial support for this study.
Protocol/project development: MG and SK. Data collection or management: DP and SK. Data analysis: SK and ZT. Manuscript writing/editing: SK, DP, HH, DT, PK, and MG.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 2.Tombal B (2012) Non-metastatic CRPC and asymptomatic metastatic CRPC: which treatment for which patient? Ann Oncol Off J Eur Soc Med Oncol Suppl 10: x251–2x58.Google Scholar
- 3.Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, (AWMF) (2016) Konsultationsfassung: Interdisziplinäre Leitlinie der Qualität S3 zur Früherken-nung, Diagnose und Therapie der verschiedenen Stadien des Prostatakarzinoms, Lang-version 4.0, 2016 AWMF Registernummer: 043/022OL, https://leitlinienprogramm-onkologie.de/Prostatakarzinom.58.0.html. Accessed 20 Nov 2018
- 4.Mottet N, Bellmunt J, Bolla M, Briers E, Cumberbatch MG, De Santis M, Fossati N, Gross T, Henry AM, Joniau S, Lam TB, Mason MD, Matveev VB, Moldovan PC, van den Bergh RC, Van den Broeck T, van der Poel HG, van der Kwast TH, Rouvière O, Schoots IG, Wiegel. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative IntentGoogle Scholar
- 5.American Urological Association (2018) [Internet]. [cited 2018 Nov 10]. https://www.auanet.org/guidelines/prostate-cancer-clinically-localized-(2017). Accessed 20 Nov 2018
- 6.Carroll PH, Mohler JL (2018) NCCN Guidelines updates: prostate cancer and prostate cancer early detection. J Natl Compr Cancer Netw JNCCN 16(5S):620–623Google Scholar
- 7.Sammon JD, Abdollah F, D’Amico A, Gettman M, Haese A, Suardi N et al (2018) Predicting life expectancy in men diagnosed with prostate cancer. Eur Urol 68(5):756–765Google Scholar
- 13.Hall WH, Jani AB, Ryu JK, Narayan S, Vijayakumar S (2005) The impact of age and comorbidity on survival outcomes and treatment patterns in prostate cancer. Prostate Cancer Prostat Dis 8(1):22–30Google Scholar
- 16.Albertsen PC, Moore DF, Shih W, Lin Y, Li H, Lu-Yao GL (2011) Impact of comorbidity on survival among men with localized prostate cancer. J Clin Oncol Off J Am Soc Clin Oncol 29(10):1335–1341Google Scholar
- 22.Leung KMYB, Hopman WM, Kawakami J (2012) Challenging the 10-year rule: The accuracy of patient life expectancy predictions by physicians in relation to prostate cancer management. Can Urol Assoc J J Assoc Urol Can 6(5):367–373Google Scholar